Get More Information on Oxygen Therapy Market - Request Sample Report
The Oxygen Therapy Market Size was valued at USD 33.82 billion in 2023 and is expected to reach USD 61.08 billion by 2032 and grow at a CAGR of 6.79% over the forecast period 2024-2032.
The oxygen therapy market is growing due to the expansion of home healthcare services, primarily by the COVID-19 pandemic. Due to the increasing number of patients, physical hospitals and agencies have acquired home-based oxygen therapy services increasingly. It has allowed patients to receive treatment where they find the most comfort and is less crowded. Thus, the demand for respiratory and other related oxygen therapy equipment is rising in suited to in-home applications.
Moreover, home healthcare homecare oxygen therapies are more portable and user-friendly. Majorly, developed regions, where healthcare facilities are advanced, such as North America, have such services on the rise. There is an increased availability of advanced home healthcare technologies as there are supportive policies in terms of reimbursement plans. Thus, patients can now efficiently handle respiratory reduction in homecare settings with adequate training.
For instance, The U.S. Centers for Medicare & Medicaid Services has implemented various reimbursement policies for home oxygen therapy. For example, the CMS expanded coverage for oxygen therapy equipment in 2020, ensuring that more patients could access necessary home-based treatments. This policy change has significantly impacted market growth in the U.S.
Moreover, the major factor contributing to the growth of the oxygen therapy market is the increased awareness of early diagnosis and treatment of respiratory conditions. Public health campaigns and numerous educational events helped educate people about untreated respiratory diseases, such as chronic obstructive pulmonary disease and asthma. At the same time, advanced diagnostic tools, such as accurate and easily accessible pulmonary function tests and imaging machines augment healthcare specialists’ ability to identify early respiratory conditions.
For instance, in 2023 Invacare launched the "Invacare Platinum Mobile Oxygen Concentrator," which features an extended battery life and enhanced portability. The product was developed in response to the increasing need for reliable and mobile oxygen therapy options for patients with chronic respiratory conditions.
Additionally, advances in portable and smart oxygen therapy devices have made it easier for patients to manage their conditions, leading to greater adoption. These devices allow for better mobility and real-time monitoring, enhancing patient comfort and compliance.
Drivers
Enhancing organizational effort in dealing with respiratory illnesses drives the market growth.
The growth of the oxygen therapy market is significantly driven by enhanced organizational efforts to combat respiratory illnesses. Governments and healthcare organizations worldwide have intensified their focus on addressing respiratory conditions, which are among the leading causes of death globally. According to the World Health Organization (WHO), chronic respiratory diseases accounted for nearly 7% of global deaths in 2022.
Moreover, in response, many countries have implemented robust healthcare policies and increased funding for respiratory care. For instance, the U.S. Department of Health and Human Services allocated over USD 4 billion in 2023 to improve respiratory care services. Moreover, key players in the oxygen therapy market have been actively expanding their product portfolios to meet the growing demand. In 2023, Philips introduced a new range of portable oxygen concentrators, which offer enhanced mobility and comfort for patients, aligning with the increasing need for at-home respiratory care solutions. These combined efforts from governments and industry are driving the market's expansion.
Restrain
High cost of oxygen therapy equipment and treatment hamper the market growth.
While oxygen therapy is essential for managing chronic respiratory conditions, the expenses associated with purchasing and maintaining devices like oxygen concentrators, cylinders, and liquid oxygen systems can be prohibitive for many patients. Additionally, insurance coverage for oxygen therapy varies widely across different regions, with some patients facing high out-of-pocket costs. For example, in the United States, Medicare coverage for home oxygen therapy is limited, often leading to financial burdens for patients who require continuous treatment.
By Product
Oxygen source equipment held the highest share of 62.44% in 2023. This is due to the high availability of oxygen concentrators, compressed gas systems, cylinders, and liquid oxygen products in the medical industry. Since these devices are important for initiating therapy, and the driver of the industry.
Based on this segment, oxygen concentrators are to register the fastest growth in the market, due to the introduction of new and energy-efficient products in the market. For instance, in May 2023, Drive DeVilbiss Healthcare launched the 1060AW, which is a 10-liter oxygen concentrator. This product is very popular in rural & semi-urban healthcare facilities and is known for its reliability, durability, and energy efficiency.
On the other hand, oxygen delivery devices are the segment to register the fastest growth, with a CAGR of 9.0% over the forecast period, as it offers a wide variety of devices designed to meet patients’ inspiratory and physiologic needs.
By Application
The chronic obstructive pulmonary disease segment held the highest market share in 2023. The growing chronic obstructive pulmonary disease patient population is fuelling the clinical need for treatment, thereby contributing to the segment growth. As per the data by the American Lung Association, in 2022, as many as 11.7 million people, or 4.6% of adults, reported a diagnosis of chronic obstructive pulmonary disease, which included chronic bronchitis and emphysema. Furthermore, the World Health Organization estimated that potentially fatal respiratory diseases such as chronic obstructive pulmonary disease, lung cancer, and tuberculosis are expected to account for almost one in five deaths globally by 2030.
By End-use
The home healthcare held the largest market share around 68.65. This is due to the growing preference for at-home treatment among patients with chronic respiratory diseases. This trend is driven by the increasing elderly population, who are more prone to conditions like COPD and require long-term oxygen therapy. Home-based care offers greater comfort, convenience, and independence for patients, reducing the need for frequent hospital visits and minimizing healthcare costs.
Need any customization research on Oxygen Therapy Market - Enquiry Now
North America held the highest market share in the oxygen therapy market around 35.21% in 2023. The dominating position of the North American region with respect to the sales of oxygen therapy products is supported by the highly developed healthcare infrastructure and high quality of life. Particularly, the healthcare delivery and equipment systems in the United States and Canada can be characterized by their advanced level of development, and significant investments in medical technologies, and respiratory therapeutics. Chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma, are prevalent across the region instigating a high demand for oxygen therapy products. Particularly, the American Lung Association reports that over 16 million Americans were diagnosed with COPD.
The Major Players are ResMed, Inogen, Inc., Fisher & Paykel Healthcare Limited, HERSILL S.L., Tecno-Gaz Industries, Allied Healthcare Products, Inc., Teleflex Incorporated, Chart Industries, Rhythm Healthcare, OMRON Healthcare, and Others
In 2024, Brezan Technologies introduced the Brezan 360 home oxygen system. This new system integrates advanced AI algorithms to optimize oxygen delivery and provide real-time data on patient usage and needs, improving both efficacy and patient compliance.
In 2023, Philips launched the EverFlo Q portable oxygen concentrator, designed for home use. This new model offers improved portability, efficiency, and user-friendly features, addressing the growing demand for at-home oxygen therapy solutions.
In 2023, ResMed introduced the AirSense 11 CPAP machine, which incorporates advanced oxygen therapy features. The device includes integrated connectivity and patient management tools, enhancing the ease of use and monitoring for respiratory patients.
| Report Attributes | Details |
| Market Size in 2023 | US$ 33.82 Billion |
| Market Size by 2032 | US$ 61.08 Billion |
| CAGR | CAGR of 6.79 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Product (Oxygen Source Equipment, Oxygen Delivery Devices) •By Application (Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia, Others) •By End-user (Home Healthcare, Non-Home Healthcare) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Masimo, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, Nonin, Diamedica (UK) Limited, EDAN Instruments, Inc., Dragerwerk AG & Co. KGaA, Dow Inc., Baxter, and others. . |
| Key Drivers | •Enhancing organizational effort in dealing with respiratory illnesses drives the market growth. |
| RESTRAINTS | •High cost of oxygen therapy equipment and treatment hamper the market growth. |
Ans: The U.S. led the Oxygen Therapy in the North America region with the highest revenue share in 2023.
Ans: Enhancing organizational effort in dealing with respiratory illnesses drives the market growth.
Ans: The home healthcare segment will grow rapidly in the Oxygen Therapy Market from 2024-2032.
Ans: The expected CAGR of the global Oxygen Therapy Market during the forecast period is 6.79%.
Ans: The Oxygen Therapy Market was valued at USD 33.82 billion in 2023.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Oxygen Therapy Market Segmentation, by Product
7.1 Chapter Overview
7.2 Oxygen Source Equipment
7.2.1 Oxygen Source Equipment Market Trends Analysis (2020-2032)
7.2.2 Oxygen Source Equipment Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Oxygen Cylinders
7.2.3.1 Oxygen Cylinders Market Trends Analysis (2020-2032)
7.2.3.2 Oxygen Cylinders Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Oxygen Concentrators
7.2.4.1 Oxygen Concentrators Market Trends Analysis (2020-2032)
7.2.4.2 Oxygen Concentrators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Liquid Oxygen Devices
7.2.5.1 Liquid Oxygen Devices Market Trends Analysis (2020-2032)
7.2.5.2 Liquid Oxygen Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 PAP Devices
7.2.6.1 PAP Devices Market Trends Analysis (2020-2032)
7.2.6.2 PAP Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6.3 CPAP
7.2.6.3.1 CPAP Market Trends Analysis (2020-2032)
7.2.6.3.2 CPAP Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6.4 APAP
7.2.6.4.1 APAP Market Trends Analysis (2020-2032)
7.2.6.4.2 APAP Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6.5 Bi-PAP
7.2.6.5.1 Bi-PAP Market Trends Analysis (2020-2032)
7.2.6.5.2 Bi-PAP Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Oxygen Delivery Devices
7.3.1 Oxygen Delivery Devices Market Trends Analysis (2020-2032)
7.3.2 Oxygen Delivery Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Oxygen Masks
7.3.3.1 Oxygen Masks Market Trends Analysis (2020-2032)
7.3.3.2 Oxygen Masks Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Nasal Cannula
7.3.4.1 Nasal Cannula Market Trends Analysis (2020-2032)
7.3.4.2 Nasal Cannula Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 Venturi Masks
7.3.5.1 Venturi Masks Market Trends Analysis (2020-2032)
7.3.5.2 Venturi Masks Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.6 Non-rebreather Masks
7.3.6.1 Non-rebreather Masks Market Trends Analysis (2020-2032)
7.3.6.2 Non-rebreather Masks Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.7 Bag Valve Masks
7.3.7.1 Bag Valve Masks Market Trends Analysis (2020-2032)
7.3.7.2 Bag Valve Masks Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.8 CPAP Masks
7.3.8.1 CPAP Masks Market Trends Analysis (2020-2032)
7.3.8.2 CPAP Masks Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.9 Others
7.3.9.1 Others Market Trends Analysis (2020-2032)
7.3.9.2Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Oxygen Therapy Market Segmentation, by Application
8.1 Chapter Overview
8.2 Chronic Obstructive Pulmonary Disease
8.2.1 Chronic Obstructive Pulmonary Disease Market Trends Analysis (2020-2032)
8.2.2 Chronic Obstructive Pulmonary Disease Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Asthma
8.3.1 Asthma Market Trends Analysis (2020-2032)
8.3.2 Asthma Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Obstructive Sleep Apnea
8.4.1 Obstructive Sleep Apnea Market Trends Analysis (2020-2032)
8.4.2 Obstructive Sleep Apnea Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Respiratory Distress Syndrome
8.5.1 Respiratory Distress Syndrome Market Trends Analysis (2020-2032)
8.5.2 Respiratory Distress Syndrome Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6.1 Cystic Fibrosis Market Trends Analysis (2020-2032)
8.6.2 Cystic Fibrosis Market Size Estimates and Forecasts to 2032 (USD Billion)
8.7 Pneumonia
8.7.1 Pneumonia Market Trends Analysis (2020-2032)
8.7.2 Pneumonia Market Size Estimates and Forecasts to 2032 (USD Billion)
8.8 Others
8.8.1 Others Market Trends Analysis (2020-2032)
8..2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Oxygen Therapy Market Segmentation, by End-Use
9.1 Chapter Overview
9.2 Home Healthcare
9.2.1 Home Healthcare Market Trends Analysis (2020-2032)
9.2.2 Home Healthcare Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Non-Home Healthcare
9.3.1 Non-Home Healthcare Market Trends Analysis (2020-2032)
9.3.2 Non-Home Healthcare Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Oxygen Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.4 North America Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.6.2 USA Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.7.2 Canada Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Oxygen Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Oxygen Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.7.2 France Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Oxygen Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.6.2 China Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.7.2 India Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.8.2 Japan Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.12.2 Australia Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Oxygen Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Oxygen Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.4 Africa Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Oxygen Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.4 Latin America Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Oxygen Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Oxygen Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Oxygen Therapy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
11. Company Profiles
11.1 ResMed
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Inogen, Inc.
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Fisher & Paykel Healthcare Limited
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 HERSILL S.L.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Tecno-Gaz Industries
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Allied Healthcare Products, Inc.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Teleflex Incorporated
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Chart Industries
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Rhythm Healthcare
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 OMRON Healthcare
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Product
Oxygen Source Equipment
Oxygen Cylinders
Oxygen Concentrators
Liquid Oxygen Devices
PAP Devices
CPAP
APAP
Bi-PAP
Oxygen Delivery Devices
Oxygen Masks
Nasal Cannula
Venturi Masks
Non-rebreather Masks
Bag Valve Masks
CPAP Masks
Others
By Application
Chronic Obstructive Pulmonary Disease
Asthma
Obstructive Sleep Apnea
Respiratory Distress Syndrome
Cystic Fibrosis
Pneumonia
Others
By End-Use
Home healthcare
Non-Home Healthcare
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
Sepsis Diagnostics Market was valued at USD 1.2 billion in 2023 and is expected to reach USD 2.5 billion by 2032, growing at a CAGR of 8.6% from 2024 to 2032.
The Drug Screening Market was valued at USD 7.6 billion in 2023 and is expected to reach USD 29.7 billion by 2032 and grow at a CAGR of 16.3% by 2024-2032.
The Dermatology Imaging Devices Market size was valued at USD 2.36 billion in 2023 and is expected to reach USD 7.04 Billion by 2032, growing at a CAGR of 12.93% from 2024-2032.
The Medical Swabs Market was valued at USD 3.15 billion in 2023 and is expected to reach USD 5.69 billion by 2032, growing at a CAGR of 6.8% by 2024-2032.
The Immunohistochemistry Market size was estimated at USD 2.54 billion in 2023 and is expected to reach USD 4.25 billion by 2032 at a CAGR of 5.9% during the forecast period of 2024-2032.
The Monoclonal Antibody Therapy Market size was valued at USD 87.8 Bn in 2023 and is expected to reach USD 230.38 Bn by 2031 with a growing CAGR of 12.8% Over the Forecast Period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
